Peptide Stapling: A Novel Approach to Cancer Drug Development
August 25, 2014•15 min
Hosted by: Bruce Bloom
Guest: Loren Walensky
Dr. Loren Walensky, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute discusses the biology of cell death and how a new chemical technology is yielding a host of new tools to study and treat diseases, like cancer, that are characterized by an imbalance of cellular life and death.